Come up with a name for your new list and we'll add to it:
Oxalo Therapeutics raised a round of funding on May 31, 2018. Investors include
University of Chicago's New Venture Challenge.
Oxalo Therapeutics is developing a drug therapy to treat and prevent recurrent kidney stones, as well as other renal diseases caused by high levels of oxalate in the body.…